BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9216684)

  • 21. [Detection of drug-drug interaction by ESR spectroscopy].
    Sakagami H; Satoh K
    Nihon Yakurigaku Zasshi; 1999 Jun; 113(6):349-56. PubMed ID: 10524361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of anticancer drugs, metals and antioxidants on cytotoxic activity of benzothiepins/benzoxepins.
    Terasawa K; Hosoya H; Sugita Y; Yokoe I; Sakagami H
    Anticancer Res; 2000; 20(5A):2951-4. PubMed ID: 11062706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ascorbate oxidase on radical intensity and cytotoxic activity of ascorbate.
    Sakagami H; Satoh K
    Anticancer Res; 1997; 17(2A):1163-6. PubMed ID: 9137465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of radical intensity and cytotoxic activity of ascorbate by hyperthermia.
    Satoh K; Sakagami H; Nakamura K
    Anticancer Res; 1996; 16(5A):2987-91. PubMed ID: 8917417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of radical intensity and cytotoxic activity of ascorbate by Crataegus cuneata Sieb et. Zucc. extracts.
    Satoh K; Anzai S; Sakagami H
    Anticancer Res; 1998; 18(4A):2749-53. PubMed ID: 9703940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of antioxidants, oxidants, metals and saliva on cytotoxicity induction by sodium fluoride.
    Tokunaga T; Morshed SR; Otsuki S; Takayama F; Satoh T; Hashimoto K; Yasui T; Ogawa S; Kanegae H; Yokote Y; Akahane K; Kashimata M; Satoh K; Sakagami H
    Anticancer Res; 2003; 23(5A):3719-26. PubMed ID: 14666669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between sodium ascorbate and polyphenols.
    Satoh K; Ida Y; Ishihara M; Sakagami H
    Anticancer Res; 1999; 19(5B):4177-86. PubMed ID: 10628372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible role of radical intensity and oxidation potential for gallic acid-induced apoptosis.
    Sakagami H; Satoh K; Hatano T; Yoshida T; Okuda T
    Anticancer Res; 1997; 17(1A):377-80. PubMed ID: 9066680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of antioxidants on radical intensity and cytotoxicity of hydroquinone.
    Terasaka H; Takayama F; Satoh K; Fujisawa S; Sakagami H
    Anticancer Res; 2000; 20(5B):3357-62. PubMed ID: 11131635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of radical intensity and cytotoxic activity of ascorbate by PSK and lignins.
    Satoh K; Sakagami H; Nakamura K
    Anticancer Res; 1996; 16(5A):2981-6. PubMed ID: 8917416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of metal ions on radical intensity and cytotoxic activity of ascorbate.
    Satoh K; Sakagami H
    Anticancer Res; 1997; 17(2A):1125-9. PubMed ID: 9137459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decline of superoxide dismutase activity during antioxidant-induced apoptosis in HL-60 cells.
    Zhang W; Hashimoto K; Yu GY; Sakagami H
    Anticancer Res; 2002; 22(1A):219-24. PubMed ID: 12017292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of antioxidants on radical intensity and cytotoxic activity of eugenol.
    Satoh K; Ida Y; Sakagami H; Tanaka T; Fujisawa S
    Anticancer Res; 1998; 18(3A):1549-52. PubMed ID: 9673369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines.
    Koh WS; Lee SJ; Lee H; Park C; Park MH; Kim WS; Yoon SS; Park K; Hong SI; Chung MH; Park CH
    Anticancer Res; 1998; 18(4A):2487-93. PubMed ID: 9703897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection by antioxidants of copper-induced decline of proliferation and SOD activity.
    Kinoshita N; Hashimoto K; Yamamura T; Teranuma H; Koizumi T; Satoh K; Katayama T; Sakagami H
    Anticancer Res; 2005; 25(1A):283-9. PubMed ID: 15816549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the type of serum in the medium on sodium ascorbate-induced cytotoxicity.
    Sakagami H; Satoh K; Sugaya K; Iida M; Hirota N; Matsumoto K; Kimura S; Gomi K; Taguchi S; Kato S; Takeda M
    Anticancer Res; 1996; 16(4A):1937-41. PubMed ID: 8712724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenolic acid derivatives with potential anticancer properties--a structure-activity relationship study. Part 1: methyl, propyl and octyl esters of caffeic and gallic acids.
    Fiuza SM; Gomes C; Teixeira LJ; GirĂ£o da Cruz MT; Cordeiro MN; Milhazes N; Borges F; Marques MP
    Bioorg Med Chem; 2004 Jul; 12(13):3581-9. PubMed ID: 15186842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of the antitumor action between sodium 5,6-benzylidene-L-ascorbate and sodium ascorbate (minireview).
    Sakagami H; Satoh K; Kochi M
    Anticancer Res; 1997; 17(6D):4451-2. PubMed ID: 9494548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chelating effect of human serum proteins on metal-catalyzed ascorbate radical generation.
    Satoh K; Ida Y; Kimura S; Taguchi K; Numaguchi M; Gomi K; Kochi M; Sakagami H
    Anticancer Res; 1997; 17(6D):4377-80. PubMed ID: 9494536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gallic acid, a metabolite of the antioxidant propyl gallate, inhibits gap junctional intercellular communication via phosphorylation of connexin 43 and extracellular-signal-regulated kinase1/2 in rat liver epithelial cells.
    Kim JH; Kang NJ; Lee BK; Lee KW; Lee HJ
    Mutat Res; 2008 Feb; 638(1-2):175-83. PubMed ID: 18054051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.